ACHVAchieve Life Sciences, Inc.

Healthcare
$7.18+116% 1Y

The financials

Achieve Life Sciences, Inc. by the numbers

The next results filing is expected around Nov 5, 2026, the same week as a year ago.

Achieve Life Sciences, Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Net income−$75M−$13Mn/a
Diluted EPS−$0.80−$0.37n/a

Biotechnology

Ranks #159 of 196 by RyuScore

Compare peers
DNA-1.1%
Ginkgo Bioworks Holdings, Inc.
DSGN-1.8%
Design Therapeutics, Inc.
VSTM-1.8%
Verastem, Inc.
CADL-1.5%
Candel Therapeutics, Inc.
AVTX-1.1%
Avalo Therapeutics, Inc.
GERN+1.3%
GERON CORP